Mads Sandahl
Papers
1
Total Citations
9
H-Index
1
About
Mads Sandahl is a rising figure in urologic oncology, whose work is sharpening the precision of prostate cancer diagnostics. His primary research focus is the optimization of MRI-targeted biopsy techniques, a critical step in moving beyond random sampling toward personalized, image-guided care. In his landmark 2022 study, Sandahl directly compared the diagnostic efficacy of manually operated versus robot-assisted in-bore MRI-targeted biopsy. This investigation provided crucial, evidence-based insight into a rapidly evolving technological landscape, addressing a significant gap in the literature regarding the relative performance of these two approaches. While his most-cited work has garnered 9 citations—a solid foundation for an emerging scholar—its impact lies in its clinical relevance, offering urologists and radiologists a clearer framework for selecting biopsy methods. Sandahl’s contributions are helping to refine the standard of care for prostate cancer detection, demonstrating a commitment to rigorous comparative effectiveness research that directly influences patient outcomes and procedural decision-making in modern urology.
Research Focus
Key Achievements
Top Papers
- 1